Pharmaceutical Advisory Board (PAB) Review

 

The links below will lead you to specific portions of the Draft Guidance for review. Please note that each section has a link to view or download a PDF of the current draft.
TIP: Please download or open with Acrobat to see previous version comments which will be helpful in your review.

 

Once you have reviewed the section, please visit the Comments & References page for that section to submit your feedback. Please note that there are line numbers for you to reference for any comments provided. 

TIP: You will be able to see all comments once you submit yours. Email addresses must be provided to comment.

 

Thank you for taking part in this important effort.

 

*Following are draft Sections as of 11/19/21

Section #1 – Benefit Risk

BENEFIT RISK DRAFT 

SUBMIT COMMENTS & REFERENCES FOR BENEFIT RISK DRAFT 

 

Section # 2 – Biomarkers

BIOMARKERS DRAFT 

SUBMIT COMMENTS & REFERENCES  FOR BIOMARKERS DRAFT

 

Section # 3 – Diagnosis

DIAGNOSIS DRAFT 

SUBMIT COMMENTS & REFERENCES  FOR DIAGNOSIS DRAFT 

 

Section #4 – Natural History

NATURAL HISTORY DRAFT 

SUBMIT COMMENTS & REFERENCES  FOR NATURAL HISTORY 

 

Section # 5 – Cardiac – DMD

CARDIAC DRAFT 

SUBMIT COMMENTS & REFERENCES FOR CARDIAC 

 

Section # 6 – Gene Therapy

GENE THERAPY DRAFT 

SUBMIT COMMENTS & REFERENCES FOR GENE THERAPY